Can-Fite BioPharma Ltd. Files 6-K for June 30, 2025
Ticker: CANF · Form: 6-K · Filed: Aug 28, 2025 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Aug 28, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 6-k, foreign-private-issuer
TL;DR
Can-Fite BioPharma dropped its Q2 2025 financials on 8/28. Check the 6-K.
AI Summary
Can-Fite BioPharma Ltd. filed a Form 6-K on August 28, 2025, reporting its financial results for the period ending June 30, 2025. The filing includes financial statements and other information relevant to its status as a foreign private issuer. The company is incorporated in Israel and its principal executive offices are located in Ramat Gan.
Why It Matters
This filing provides investors with updated financial information for Can-Fite BioPharma, crucial for assessing the company's performance and financial health.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) and does not contain new material events or significant financial changes.
Key Numbers
- June 30, 2025 — Reporting Period End (Financial results are reported as of this date.)
- August 28, 2025 — Filing Date (Date the report was submitted to the SEC.)
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Filer of the report
- 20250630 (date) — Reporting period end date
- 20250828 (date) — Filing date
- Ramat Gan (location) — Location of principal executive offices
- Israel (location) — Country of incorporation
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed for the month of August 2025, incorporating by reference financial results and other information.
What is the reporting period for the financial information in this filing?
The Conformed Period of Report is June 30, 2025.
When was this Form 6-K filed with the SEC?
The filing date is August 28, 2025.
Where are Can-Fite BioPharma Ltd.'s principal executive offices located?
The principal executive offices are located at 26 Ben Gurion Street, Ramat Gan, 5257346, Israel.
Which SEC registration statements does this filing incorporate by reference?
This filing incorporates by reference into the registrant's Registration Statements on Form S-8 (File Nos. 333-227753, 333-271384 and 333-278525) and Form F-3.
Filing Stats: 477 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-08-28 08:49:44
Filing Documents
- ea0254606-6k_canfite.htm (6-K) — 26KB
- ea025460601ex99-1_canfite.htm (EX-99.1) — 85KB
- ea025460601ex99-2_canfite.htm (EX-99.2) — 310KB
- ea025460601ex99-3_canfite.htm (EX-99.3) — 57KB
- ex99-3_001.jpg (GRAPHIC) — 29KB
- 0001213900-25-081407.txt ( ) — 2935KB
- canf-20250630.xsd (EX-101.SCH) — 31KB
- canf-20250630_cal.xml (EX-101.CAL) — 21KB
- canf-20250630_def.xml (EX-101.DEF) — 147KB
- canf-20250630_lab.xml (EX-101.LAB) — 296KB
- canf-20250630_pre.xml (EX-101.PRE) — 163KB
- ea0254606-6k_canfite_htm.xml (XML) — 254KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 28, 2025 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer 3